ACCORDI, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.890
AS - Asia 2.458
EU - Europa 1.059
AF - Africa 346
SA - Sud America 332
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 37
Totale 9.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.657
SG - Singapore 766
CN - Cina 492
VN - Vietnam 365
HK - Hong Kong 256
BR - Brasile 195
DE - Germania 184
IT - Italia 141
FI - Finlandia 98
IN - India 87
FR - Francia 84
GB - Regno Unito 74
PL - Polonia 68
BD - Bangladesh 59
CA - Canada 57
RU - Federazione Russa 56
SE - Svezia 50
JP - Giappone 37
TR - Turchia 33
MX - Messico 31
UA - Ucraina 31
AR - Argentina 29
ZA - Sudafrica 29
NL - Olanda 28
IQ - Iraq 27
PH - Filippine 26
UZ - Uzbekistan 23
EC - Ecuador 22
SA - Arabia Saudita 22
PK - Pakistan 21
CO - Colombia 20
AT - Austria 19
JM - Giamaica 18
MA - Marocco 18
VE - Venezuela 18
ES - Italia 17
HN - Honduras 16
ID - Indonesia 16
AO - Angola 15
JO - Giordania 15
TJ - Tagikistan 15
CI - Costa d'Avorio 14
KR - Corea 14
AZ - Azerbaigian 13
BJ - Benin 13
IE - Irlanda 13
AM - Armenia 12
CH - Svizzera 12
CV - Capo Verde 12
DK - Danimarca 12
ET - Etiopia 12
KG - Kirghizistan 12
RE - Reunion 12
CL - Cile 11
DZ - Algeria 11
EG - Egitto 11
GH - Ghana 11
GR - Grecia 11
KE - Kenya 11
MK - Macedonia 11
TN - Tunisia 11
AL - Albania 10
BG - Bulgaria 10
BZ - Belize 10
GM - Gambi 10
IS - Islanda 10
MY - Malesia 10
NA - Namibia 10
PE - Perù 10
RS - Serbia 10
TT - Trinidad e Tobago 10
AU - Australia 9
CM - Camerun 9
CZ - Repubblica Ceca 9
KZ - Kazakistan 9
LB - Libano 9
LV - Lettonia 9
MN - Mongolia 9
PS - Palestinian Territory 9
SI - Slovenia 9
SN - Senegal 9
SY - Repubblica araba siriana 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BA - Bosnia-Erzegovina 8
BB - Barbados 8
BO - Bolivia 8
BW - Botswana 8
CG - Congo 8
CU - Cuba 8
CY - Cipro 8
HT - Haiti 8
IL - Israele 8
IR - Iran 8
KH - Cambogia 8
ML - Mali 8
NI - Nicaragua 8
TH - Thailandia 8
YE - Yemen 8
BY - Bielorussia 7
Totale 8.817
Salva come PNG Salva come JPEG
Città #
Ashburn 528
Fairfield 513
Singapore 488
San Jose 448
Woodbridge 341
Chandler 319
Hong Kong 241
Ann Arbor 240
Cambridge 217
Houston 181
Seattle 175
Wilmington 155
Ho Chi Minh City 112
Beijing 100
Hanoi 97
Santa Clara 87
Los Angeles 78
Boardman 62
Jacksonville 58
San Diego 57
Helsinki 56
Princeton 45
Bytom 43
New York 43
Lauterbourg 35
Medford 35
Chicago 34
Munich 31
Padova 29
Des Moines 27
Tokyo 26
Da Nang 22
Tashkent 22
Nanjing 21
Orem 21
Council Bluffs 20
Haiphong 17
Montreal 17
Buffalo 16
Guangzhou 16
London 16
São Paulo 16
Atlanta 15
Chennai 15
Denver 15
Turku 15
Abidjan 14
Amman 14
Luanda 14
Redondo Beach 14
Shenyang 14
Warsaw 14
Cotonou 13
Dushanbe 13
Johannesburg 13
Shanghai 13
Vienna 13
Baku 12
Brooklyn 12
Dong Ket 12
Frankfurt am Main 12
Kingston 12
Bishkek 11
Dublin 11
Nuremberg 11
Rio de Janeiro 11
Addis Ababa 10
Biên Hòa 10
Dallas 10
Guayaquil 10
Istanbul 10
San Pedro Sula 10
The Dalles 10
Yerevan 10
Boston 9
Dakar 9
Montevideo 9
Nairobi 9
North York 9
Poplar 9
Praia 9
Sofia 9
Toronto 9
Ulan Bator 9
Amsterdam 8
Ankara 8
Hangzhou 8
Hefei 8
Jeddah 8
Jiaxing 8
Jinan 8
Ottawa 8
Phnom Penh 8
Quito 8
San Francisco 8
Stockholm 8
Accra 7
Apia 7
Bamako 7
Conakry 7
Totale 5.712
Salva come PNG Salva come JPEG
Nome #
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 426
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 358
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 314
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 305
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL 285
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 283
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 281
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 274
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 273
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All) 272
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma 272
Annexin 2A sustains glioblastoma cell dissemination and proliferation 270
AMPK INHIBITION INDUCES APOPTOSIS IN PEDIATRIC B-ALL CELLS WITH MLL GENE REARRANGEMENTS 268
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 267
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 267
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 253
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 248
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 245
Hovering between death and life: Natural apoptosis and phagocytes in the blastogenetic cycle of the colonial ascidian Botryllus schlosseri 244
Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells 242
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 235
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 233
Reverse Phase Protein Array (RPPA) of High Risk ALL 230
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction 225
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia 223
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 211
Expression and role of hERG1 channels in pediatric acute lymphoblastic Leukemias: Shortcoming of drug resistance by hERG1 channel inhibitors in stoma-supported leukaemia cell cultures in vitro. 206
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction 175
NUP214-ABL1 fusion in childhood T-ALL 172
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. 169
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 163
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 158
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 158
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. 155
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. 152
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy 149
Validation by RQ-PCR and flow cytometry of alpha-defensin 1-3 (DEFA 1-3) overexpression in relapsed and refractory acute lymphoblastic leucemia. 144
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 142
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. 132
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 122
Totale 9.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.932
article - articoli 26.932
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022602 0 52 69 33 23 35 113 43 28 15 75 116
2022/2023556 91 78 17 87 67 68 0 37 65 7 31 8
2023/2024252 11 50 29 21 21 26 16 10 7 15 25 21
2024/20251.014 1 75 44 45 130 24 50 97 86 34 167 261
2025/20264.346 226 299 471 667 369 194 779 320 555 230 165 71
2026/2027300 124 176 0 0 0 0 0 0 0 0 0 0
Totale 9.201